NEW: We've expanded Stock Detail, Screener, and Maps with new data

Stock Detail, Screener:
3, 5, 10-Year Performance
EV/EBITDA, EV/Sales
Dividend Growth (1, 3, 5 Years)
EPS & Sales Growth (3 Years)

Maps:
All from Screener plus:
ROA, ROE, ROIC
Quick & Current Ratios
LT Debt and Debt to Equity Ratios
Gross, Operating, and Net Margins

Last Close
Jun 20 04:00PM ET
1.20
Dollar change
-0.01
Percentage change
-0.83
%
Index- P/E- EPS (ttm)-2.77 Insider Own16.98% Shs Outstand13.47M Perf Week-9.09%
Market Cap18.01M Forward P/E- EPS next Y-1.17 Insider Trans-1.10% Shs Float12.46M Perf Month-10.45%
Enterprise Value4.97M PEG- EPS next Q-0.35 Inst Own7.90% Short Float3.69% Perf Quarter-31.82%
Income-25.57M P/S8.08 EPS this Y52.29% Inst Trans1.85% Short Ratio3.39 Perf Half Y-34.07%
Sales2.23M P/B1.05 EPS next Y6.13% ROA-110.81% Short Interest0.46M Perf YTD-30.64%
Book/sh1.15 P/C1.26 EPS next 5Y55.56% ROE-167.57% 52W Range1.14 - 6.40 Perf Year-50.00%
Cash/sh0.95 P/FCF- EPS past 3/5Y31.57% -11.05% ROIC-143.50% 52W High-81.25% Perf 3Y-98.19%
Dividend Est.- EV/EBITDA- Sales past 3/5Y22.35% -15.76% Gross Margin31.69% 52W Low5.26% Perf 5Y-
Dividend TTM- EV/Sales2.23 EPS Y/Y TTM71.16% Oper. Margin-791.51% Volatility2.39% 3.63% Perf 10Y-
Dividend Ex-Date- Quick Ratio5.61 Sales Y/Y TTM127.51% Profit Margin-1149.39% RSI (14)39.12 Recom1.00
Dividend Gr. 3/5Y- - Current Ratio5.61 EPS Q/Q79.24% SMA20-5.77% Beta0.20 Target Price8.67
Payout- Debt/Eq0.08 Sales Q/Q-30.47% SMA50-14.29% Rel Volume0.38 Prev Close1.21
Employees26 LT Debt/Eq0.04 EarningsMay 08 AMC SMA200-30.08% Avg Volume135.56K Price1.20
IPOFeb 12, 2021 Option/ShortNo / Yes EPS/Sales Surpr.-3.03% -35.72% Trades Volume52,079 Change-0.83%
Date Action Analyst Rating Change Price Target Change
Dec-06-24Initiated ROTH MKM Buy $10
Jun-09-25 09:15AM
May-20-25 09:15AM
May-12-25 07:15AM
May-08-25 04:05PM
May-02-25 08:30AM
04:05PM Loading…
Apr-22-25 04:05PM
Mar-20-25 09:00AM
Mar-11-25 08:30AM
Mar-05-25 09:25AM
Feb-28-25 04:04PM
Feb-21-25 08:30AM
Feb-19-25 06:00AM
Feb-18-25 09:25AM
Feb-14-25 09:05AM
Dec-18-24 09:10AM
05:20AM Loading…
Dec-07-24 05:20AM
Dec-04-24 07:00AM
Dec-03-24 07:00AM
Dec-02-24 09:05AM
Nov-12-24 04:05PM
Nov-11-24 09:05AM
Nov-04-24 04:05PM
Oct-29-24 10:00AM
Oct-27-24 03:10PM
Oct-14-24 09:05AM
Oct-09-24 09:05AM
Oct-07-24 09:05AM
Oct-02-24 09:05AM
Sep-26-24 09:05AM
Sep-03-24 09:00AM
04:05PM Loading…
Aug-26-24 04:05PM
Aug-14-24 04:05PM
Aug-05-24 04:05PM
Jul-28-24 04:51PM
Jul-19-24 04:05PM
Jul-18-24 08:45AM
Jul-17-24 08:00AM
Jul-10-24 12:08PM
11:34AM
07:30AM
Jul-09-24 09:00AM
Jul-08-24 09:00AM
Jun-21-24 08:35AM
Jun-19-24 10:30AM
Jun-18-24 04:48PM
08:35AM
Jun-17-24 09:45AM
09:00AM
08:38AM
Jun-12-24 07:00AM
Jun-11-24 09:00AM
07:00AM
Jun-10-24 09:00AM
Jun-03-24 09:00AM
May-28-24 08:05AM
May-14-24 04:05PM
May-10-24 04:05PM
May-02-24 08:03AM
Apr-29-24 09:00AM
Apr-25-24 04:05PM
Apr-19-24 12:13PM
Apr-18-24 04:05PM
Apr-17-24 08:00AM
Apr-16-24 01:08PM
Apr-15-24 08:30AM
08:24AM
Apr-11-24 05:17PM
Apr-08-24 02:15PM
08:30AM
07:56AM
Mar-19-24 04:01PM
Feb-28-24 10:05AM
09:19AM
Feb-27-24 04:05PM
Feb-21-24 04:05PM
Jan-29-24 08:00AM
Dec-22-23 04:05PM
Dec-21-23 10:34AM
08:00AM
Dec-20-23 08:00AM
Nov-14-23 08:17AM
Nov-11-23 09:00AM
08:38AM
Nov-10-23 07:30AM
Nov-03-23 08:00AM
Oct-24-23 08:30AM
Oct-13-23 04:05PM
Oct-12-23 08:00AM
Oct-05-23 07:00AM
Sep-12-23 09:00AM
Sep-11-23 08:00AM
Sep-07-23 08:30AM
08:00AM
Sep-05-23 08:00AM
07:00AM
Aug-29-23 08:00AM
Aug-22-23 08:00AM
Aug-16-23 09:13AM
Aug-14-23 04:05PM
08:00AM
Longeveron, Inc. is a clinical stage biotechnology company, which engages in the development of cellular therapies for specific aging-related and life-threatening conditions. Its lead product, LOMECEL-B, is a cell-based therapy product, which is derived from culture-expanded medicinal signaling cells that are sourced from bone marrow of young, healthy, adult donors. The company was founded by Joshua M. Hare and Donald M. Soffer on October 9, 2014 and is headquartered in Miami, FL.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Soffer RockDirectorMay 30 '25Sale1.2511,00013,750209,034Jun 02 06:00 PM
Soffer RockDirectorMay 29 '25Sale1.3010,00013,000220,034Jun 02 06:00 PM
Rock SofferDirectorMay 29 '25Proposed Sale1.2721,00026,775May 29 05:34 PM
Soffer RockDirectorMay 22 '25Sale1.322,0002,640230,034May 27 06:52 PM
Hare JoshuaChief Scientific OfficerMay 16 '25Sale1.405,2507,367721,796May 16 06:00 PM
Hare JoshuaOfficerMay 15 '25Proposed Sale1.385,2507,220May 15 03:20 PM
Baluch KhosoDirectorDec 02 '24Sale2.071,2502,58823,750Dec 04 06:00 PM
Baluch KhosoDirectorNov 27 '24Proposed Sale2.061,2502,575Nov 27 04:43 PM